• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动脉瓣上狭窄成功手术矫正后发生肥厚型心肌病:威廉姆斯-贝伦综合征病例报告

Hypertrophic cardiomyopathy occurred after successful surgical correction of supravalvular aortic stenosis: a case report of Williams-Beuren syndrome.

作者信息

Yu Hongxiao, Ruan Yang, Sun Manfang, Li Taole, Nie Zhihua

机构信息

Department of Cardiology, Haicang Hospital, Haicang, Xiamen, China.

The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, China.

出版信息

Front Pediatr. 2025 Aug 8;13:1580272. doi: 10.3389/fped.2025.1580272. eCollection 2025.

DOI:10.3389/fped.2025.1580272
PMID:40861045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12370502/
Abstract

Williams-Beuren syndrome (WBS) is a multisystemic disorder caused by a microdeletion on chromosome 7q11.23.The supravalvular aortic stenosis (SVAS) is the most prevalent cardiovascular complication of WBS. However, hypertrophic cardiomyopathy (HCM) has rarely been reported in this population. We present a case of a patient with WBS who underwent successful surgical repair for SVAS in infancy but later developed HCM. Comprehensive genetic testing and further bioinformatic analysis revealed a deletion of approximately 1,486 kb at the 7q11.23 locus, and subsequent echocardiography demonstrated characteristic features of HCM. This case highlights the rare but clinically significant association between WBS and HCM, providing a foundation for further investigation into the biological mechanisms or potential biomarkers for HCM in WBS patients.

摘要

威廉姆斯-贝伦综合征(WBS)是一种由7号染色体q11.23区域微缺失引起的多系统疾病。瓣上主动脉狭窄(SVAS)是WBS最常见的心血管并发症。然而,肥厚型心肌病(HCM)在该人群中鲜有报道。我们报告一例WBS患者,该患者婴儿期因SVAS接受了成功的手术修复,但后来发展为HCM。全面的基因检测和进一步的生物信息学分析显示,7q11.23位点缺失约1486 kb,随后的超声心动图显示了HCM的特征性表现。该病例突出了WBS与HCM之间罕见但具有临床意义的关联,为进一步研究WBS患者HCM的生物学机制或潜在生物标志物奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/24d559c0477e/fped-13-1580272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/454451380f66/fped-13-1580272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/10b4e6e1bd31/fped-13-1580272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/24d559c0477e/fped-13-1580272-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/454451380f66/fped-13-1580272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/10b4e6e1bd31/fped-13-1580272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9967/12370502/24d559c0477e/fped-13-1580272-g003.jpg

相似文献

1
Hypertrophic cardiomyopathy occurred after successful surgical correction of supravalvular aortic stenosis: a case report of Williams-Beuren syndrome.主动脉瓣上狭窄成功手术矫正后发生肥厚型心肌病:威廉姆斯-贝伦综合征病例报告
Front Pediatr. 2025 Aug 8;13:1580272. doi: 10.3389/fped.2025.1580272. eCollection 2025.
2
Increased heart rate fragmentation in those with Williams-Beuren syndrome suggests nonautonomic mechanistic contributors to sudden death risk.威廉姆斯-贝伦综合征患者的心率碎裂增加提示非自主机制可能导致猝死风险。
Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H521-H532. doi: 10.1152/ajpheart.00601.2023. Epub 2024 Jun 21.
3
Supravalvular aortic stenosis mimicking hypertrophic obstructive cardiomyopathy: a case report.酷似肥厚型梗阻性心肌病的瓣上主动脉狭窄:一例报告
Eur Heart J Case Rep. 2025 Jun 28;9(7):ytaf312. doi: 10.1093/ehjcr/ytaf312. eCollection 2025 Jul.
4
Clinical course and outcomes of supravalvular aortic stenosis in adults.成人主动脉瓣上狭窄的临床病程及转归
Open Heart. 2025 May 27;12(1):e003355. doi: 10.1136/openhrt-2025-003355.
5
Williams Syndrome威廉姆斯综合征
6
A systematic review and meta-analysis of the efficacy and safety of Mavacamten therapy in international cohort of 524 patients with hypertrophic cardiomyopathy.马伐卡坦治疗524例肥厚型心肌病国际队列患者疗效和安全性的系统评价与荟萃分析。
Heart Fail Rev. 2024 Mar;29(2):479-496. doi: 10.1007/s10741-023-10375-6. Epub 2023 Dec 19.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
An unusual combination of an atypical maternally inherited novel 0.3 Mb deletion in Williams-Beuren region and a de novo 22q11.21 microduplication in an infant with supravalvular aortic stenosis.先证者患有单纯性主动脉瓣上狭窄,携带罕见的、非典型的、母系遗传的威廉姆斯-贝伦综合征区域内 0.3Mb 大小的新型缺失,以及新发的 22q11.21 微重复。
Eur J Med Genet. 2020 Dec;63(12):104084. doi: 10.1016/j.ejmg.2020.104084. Epub 2020 Oct 9.
9
Congenital heart defects and postoperative follow-up of patients with Williams syndrome as a single center experience and review of the cases from Türkiye.威廉姆斯综合征患者的先天性心脏缺陷及术后随访:单中心经验及来自土耳其的病例回顾
Turk J Pediatr. 2024 May 23;66(2):215-225. doi: 10.24953/turkjpediatr.2024.4591.
10
A Systematic Review of Clinical Trials on Mavacamten in Hypertrophic Cardiomyopathy.马伐卡坦治疗肥厚型心肌病临床试验的系统评价
Heart Int. 2025 Jun 26;19(1):31-40. doi: 10.17925/HI.2025.19.1.7. eCollection 2025.

本文引用的文献

1
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2024 AHA/ACC/AMSSM/HRS/PACES/SCMR 肥厚型心肌病管理指南:美国心脏协会/美国心脏病学会联合临床实践指南委员会的报告。
Circulation. 2024 Jun 4;149(23):e1239-e1311. doi: 10.1161/CIR.0000000000001250. Epub 2024 May 8.
2
Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study.先天性主动脉瓣上狭窄的长期手术结果:系统评价、荟萃分析和微观模拟研究。
Eur J Cardiothorac Surg. 2024 Jan 2;65(1). doi: 10.1093/ejcts/ezad360.
3
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
马卡丹特:一种用于梗阻性肥厚型心肌病的首创肌球蛋白抑制剂。
Eur Heart J. 2023 Nov 21;44(44):4622-4633. doi: 10.1093/eurheartj/ehad637.
4
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.肥厚型心肌病患者行间隔心肌切除术的治疗:VALOR-HCM 随机临床试验第 56 周的结果。
JAMA Cardiol. 2023 Oct 1;8(10):968-977. doi: 10.1001/jamacardio.2023.3342.
5
Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients.马卡丹特:治疗肥厚型心肌病的精准药物——从肌球蛋白到患者
Sci Adv. 2023 Jul 28;9(30):eabo7622. doi: 10.1126/sciadv.abo7622.
6
Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy.肥厚型心肌病的遗传和分子机制。
Int J Mol Sci. 2023 Jan 28;24(3):2522. doi: 10.3390/ijms24032522.
7
Upregulation of key genes Eln and Tgfb3 were associated with the severity of cardiac hypertrophy.关键基因 Eln 和 Tgfb3 的上调与心脏肥大的严重程度相关。
BMC Genomics. 2022 Aug 14;23(1):592. doi: 10.1186/s12864-022-08778-0.
8
Elastin, arterial mechanics, and stenosis.弹性蛋白、动脉力学与狭窄。
Am J Physiol Cell Physiol. 2022 May 1;322(5):C875-C886. doi: 10.1152/ajpcell.00448.2021. Epub 2022 Feb 23.
9
Williams syndrome.威廉姆斯综合征。
Nat Rev Dis Primers. 2021 Jun 17;7(1):42. doi: 10.1038/s41572-021-00276-z.
10
Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy.弹性蛋白血管病患者的遗传诊断与心血管表型严重程度。
Circ Genom Precis Med. 2020 Dec;13(6):e002971. doi: 10.1161/CIRCGEN.120.002971. Epub 2020 Sep 22.